Therapy for gist
MA40368AUndetermined Publication Date: 2017-05-10IMCLONE LLC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MA40368
- Authority / Receiving Office
- MA · MA
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2014-07-03
- Filing Date
- 2015-06-26
- Publication Date
- 2017-05-10
Abstract
The invention provides for the human antibodies that bind to human platelet-derived growth factor receptor alpha (pdgfr alpha), preferably olaratumab, for the treatment of gastrointestinal stromal tumors with pdgfr alpha mutations including d842v.
Need to check novelty before this filing date? Find Prior Art